BIIB R&D Expenses

Biogen · R&D Expenses

BIIB logo

BIIB R&D Expenses

Latest reported$495.60M
BIIB Quarterly R&D Expenses ($0.00 → $495.60M)
High-resolution chart · PNG

BIIB r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biogen R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
495,599,999
573,000,000
509,300,000
369,600,000
529,900,000
545,900,000
683,500,000
673,000,000
592,300,000
523,700,000
647,500,000
797,200,000
637,100,000
620,800,000
776,600,000
605,700,000
596,100,000
618,600,000
767,600,000
813,400,000
1,207,200,000
612,300,000
1,975,300,000
1,223,500,000
709,100,000
622,800,000
691,700,000
540,400,000
484,800,000
563,700,000
611,600,000
535,400,000
1,056,000,000
506,700,000
587,600,000
446,400,000
916,200,000
423,400,000
533,900,000
529,000,000
473,100,000
437,300,000
541,700,000
519,900,000
490,700,000
460,500,000
500,069,000
417,174,000
447,273,000
528,884,000
433,933,000
410,017,000
327,463,000
284,340,000
388,881,000
304,217,000
329,559,000
355,962,000
338,934,000
301,391,000
285,644,000
293,633,000
45,869,000
524,054,000
331,675,000
347,006,000
283,082,000
304,055,000
416,453,000
279,478,000
292,767,000
268,800,000
252,259,000
258,232,000
229,292,000
286,274,000
218,149,000
191,449,000
530,000,000
211,033,000
161,985,000
145,892,000
168,314,000
227,039,000
179,843,000
172,477,000
189,444,000
168,307,000
169,782,000
158,920,000
730,714,000
39,333,000
50,141,000
31,910,000
91,201,000
104,551,000
89,348,000
82,467,000
83,773,000
78,895,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.